Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Real-world practice patterns and attitudes towards de-escalation of bone-modifying agents in patients with bone metastases from breast and prostate cancer: A physician survey

Mashari AlZahrani,Mark Clemons,Lisa Vandermeer,Marta Sienkiewicz,Arif Ali Awan,Brian Hutton,Gregory R Pond,Terry L Ng

Journal of Bone Oncology（2021）

Cited 8|Views27
No score
Abstract
•Questions around optimal use of bone-modifying agents (BMAs) still exist.•Most physicians are de-escalating BMAs in patients with metastatic breast cancer.•Practice varies according to patient insurance coverage.•There is interest performing further trials of de-escalation especially after 2 years of treatment.
More
Translated text
Key words
Bone metastasis,Bone modifying agent,Survey,Zoledronate,Pamidronate,Denosumab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined